MedTrace Logo

Protein Bioavailability of Wolffia Globosa (Mankai); Acute Test Meal Effects

NCT03020225 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2022-04-05

Study results available
· View outcomes & findings →

Summary

The investigators aim to test the protein bioavailability of new specific developed strain of duckweed \[Wolffia globose, Mankai\] , an aquatic plant, which might serve as a protein source and contains all the 9 essential and the 6 conditional amino acids. The investigators will randomize 36 participants to consume equivalent protein (30gr) content of 3 whole foods items: 1. White cheese (animal protein source, as a reference); 2. Green peas, intact, cooked (plant protein source); 3. Wolffia globosa (Mankai), intact, cooked (plant protein source). The foods will be consumed in the morning, following 12h fasting. The foods will be provided with 250ml mineral water and the blood follow-up frame will be for 3 hours. Primary outcome: Blood amino acid profile.

Conditions

  • Men With Mild Abdominal Obesity

Interventions

DIETARY_SUPPLEMENT

White cheese

animal protein food source: White cheese (contains 30g protein), intact, plus 250ml mineral water

DIETARY_SUPPLEMENT

Green peas

Green peas (contains 30g protein), intact, cooked, plus 250ml mineral water

DIETARY_SUPPLEMENT

Mankai

Wolffia globosa (Mankai, contains 30g protein), intact, cooked, plus 250ml mineral water

Sponsors & Collaborators

  • Harvard School of Public Health (HSPH)

    collaborator OTHER

  • University of Leipzig

    collaborator OTHER

  • Ben-Gurion University of the Negev

    lead OTHER

Principal Investigators

  • Shai · Ben-Gurion University of the Negev

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-02-28
Completion
2017-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03020225 on ClinicalTrials.gov